BIOY GraniteShares YieldBOOST Biotech ETF
Synthetic covered call on XBI, paying weekly
Since its launch on May 5, 2026, BIOY paid 20.6% in cash and still finished 15.3 points behind XBI.
Key facts
What a holder got
Over the year to Sep 18, 2026, BIOY returned +2.0% with distributions reinvested and Biotech (XBI), used as the proxy returned +17.3%, so a holder came out behind it by 15.3 points. The lighter segment is the 20.6% that arrived as cash rather than as price.
Period by period
| Window | Cash paid | Price | Total return | XBI | Ahead or behind |
|---|---|---|---|---|---|
| 3 months | 14.1% | −11.8% | +2.5% | +11.5% | −9.0 pts |
| Since launch | 20.6% | −19.0% | +2.0% | +17.3% | −15.3 pts |
In plain words
Since it launched on May 5, 2026, BIOY has returned +2.0% with distributions reinvested, against +17.3% for Biotech (XBI), used as the proxy, and has paid out 20.6% of its starting value in cash along the way. It pays weekly, and at its current price the latest distribution annualizes to 60.0%. GraniteShares estimates that 96% of the distribution paid Aug 25, 2026 was a return of capital. That is the issuer’s own Rule 19a-1 estimate and a tax characterization, made before the fund year closes: it says the payment included money the fund gave back rather than earned, not that the fund is eroding.
| Strategy | synthetic covered call |
|---|---|
| Benchmark | Biotech (XBI), used as the proxy (proxy) |
| Pays | weekly |
| Net assets (issuer page, as of Sep 18, 2026) | $1m |
| Latest payout, annualized (ETFIQ) | 60.0% |
| Expense ratio (485BPOS XBRL, Oct 24, 2025) | 1.07% |
| Cash paid, last 12 months, over today’s price (ETFIQ) | 25.4% |
| Launched | May 5, 2026 |
| Return of capital, latest distribution (GraniteShares 19a-1 estimate) | 96.3% |
Every figure is an ETFIQ calculation from exchange prices and cash distributions (Tiingo end-of-day), total return with distributions reinvested. Return of capital is the issuer’s estimate. How these figures are computed
Questions people ask
- How much has BIOY paid over the last year?
- Over the period from its launch on May 5, 2026 to Sep 18, 2026, BIOY paid 20.6% of its starting price in cash distributions, while the price fell 19.0%.
- Is BIOY ahead of XBI?
- Over the period from its launch on May 5, 2026 to Sep 18, 2026, with every distribution reinvested, BIOY returned +2.0% against +17.3% for Biotech (XBI), used as the proxy, so a holder was behind it by 15.3 points.
- How often does BIOY pay, and how much?
- BIOY pays weekly. The latest distribution annualizes to 60.0% at its price on Sep 18, 2026, which is not a promise; the next one can differ.
- Is the BIOY distribution return of capital?
- GraniteShares estimates 96% of the distribution paid Aug 25, 2026 was return of capital. That is a tax characterization from the fund's own 19a-1 notice, not a measure of erosion.
- What does BIOY cost?
- The prospectus expense ratio is 1.07% a year.
The words on this page
- Total return
- What a holder actually ended up with: price change plus every distribution, reinvested. The only figure that answers whether you came out ahead.
- Cash paid
- Distributions over the window as a share of what the fund cost at the start. A measure of cash delivered, not of return: a fund can pay a great deal and still lose money.
- Ahead or behind
- The fund’s total return minus the benchmark’s over exactly the same days, in percentage points. Both sides reinvest.
- Return of capital
- The issuer’s own estimate, in a Rule 19a-1 notice, of how much of a distribution was your own money returned. An estimate and a tax characterization, not a measure of erosion.
- Covered call
- Selling call options on shares the fund holds. It collects a premium and gives up the gains above the strike, which is why these funds pay well and lag a rising market.
Every term used here, defined in full on the income ETFs vocabulary page.
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Compare BIOY
Also against GPTY, HAKY, MDST, MLPD, NDIV, NUKX, SEMY, SOXY, TDVI, TECY, TYLG, USOY, WEEI, WEPN, XLBI, XLCI, XLEI, XLFI, XLII, XLKI, XLSI, XLUI, XLVI, XLYI, YRAM.
Funds near this one
Where BIOY is written about
Use this data, or open the live card
Open BIOY live on ETFIQ, where the figures refresh with the data.
Cite this page. ETFIQ, BIOY, income ETFs, data as of Sep 18, 2026. https://etfiq.com/funds/bioy Free to use with attribution; the underlying files are at Open data.